Headline
The latest stories from AHA Today.
The AHA responded to a RAND Corporation study that found certain prices paid to hospitals by private health plans are high relative to Medicare. The study examined hospital prices for a limited number of employers and health plans from 2016 to 2018.
The Centers for Medicare & Medicaid Services finalized a new Center for Medicare and Medicaid Innovation payment model aimed at transforming kidney care to ensure patients with chronic kidney disease have access to high quality, coordinated care.
The Centers for Medicare & Medicaid Services issued a final rule setting forth a five-year bundled payment model for radiation oncology, which will be mandatory in certain areas of the country beginning Jan. 1.
Proactive COVID-19 testing of all long-term care staff and residents, who are usually at higher risk of contracting the virus, may help prevent potential outbreaks, according to a Centers for Disease Control and Prevention study.
The Food and Drug Administration approved a new drug application for propofol injectable emulsion, an intravenous general anesthetic and sedation drug in short supply.
In a sample of 598 hospitalized pregnant women with COVID-19, 55% had no symptoms on admission, according to a report released by the Centers for Disease Control and Prevention.
The Centers for Disease Control and Prevention updated its testing guidance for SARS-CoV-2, the virus that causes COVID-19.
Government Accountability Office agents made 31 covert phone calls to selected sales representatives in five states between November 2019 and January 2020, posing as individuals needing to purchase health insurance to cover pre-existing conditions to see whether the representatives engaged in…
An estimated 29.6 million (9.2%) U.S. residents lacked health coverage when surveyed in 2019, up from 28.6 million (8.9%) in 2018, according to American Community Survey data reported by the Census Bureau.
The Centers for Disease Control and Prevention has released evidence-based recommendations to prevent and control Staphylococcus aureus in neonatal intensive care units, including strains resistant (MRSA) or sensitive (MSSA) to the antibiotic methicillin.